A Look Back at India’s Top IP Developments of 2021
SpicyIP
JANUARY 2, 2022
Particularly, it was argued that against the backdrop of the pandemic, the medicines produced were in high demand due to their characteristics of relieving some of the major symptoms exhibited by the patients who had contracted the Covid-19 virus. This patent protection was challenged by La Renon before the IPAB under section 64.
Let's personalize your content